Effects of somatostatin on renal function in cirrhosis.

[1]  W. Jiménez,et al.  Assessment of the renin-angiotensin system in cirrhotic patients. Comparison between plasma renin activity and direct measurement of immunoreactive renin. , 1992, Journal of hepatology.

[2]  J. Llach,et al.  Renal insensitivity to atrial natriuretic peptide in patients with cirrhosis and ascites: Effect of increasing systemic arterial pressure , 1992 .

[3]  B. Schneeweiss,et al.  Ornipressin in the treatment of functional renal failure in decompensated liver cirrhosis: Effects on renal hemodynamics and atrial natriuretic factor , 1991 .

[4]  B. Schneeweiss,et al.  Ornipressin in the treatment of functional renal failure in decompensated liver cirrhosis , 1991 .

[5]  Z. Tulassay,et al.  Effects of long acting somatostatin analogue on renal functions. , 1990, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[6]  J. Christiansen,et al.  Acute Effects of a Somatostatin Analogue on Kidney Function in Type 1 Diabetic Patients , 1990, Diabetic medicine : a journal of the British Diabetic Association.

[7]  J. Llach,et al.  Effects of intravenous amino acid infusion and dietary proteins on kidney function in cirrhosis , 1990, Hepatology.

[8]  E. D. Del Pozo,et al.  Antidiuretic effect of Sandostatin (SMS 201-995) in healthy volunteers. , 1989, Acta endocrinologica.

[9]  K. Lenz,et al.  Beneficial effect of 8-ornithin vasopressin on renal dysfunction in decompensated cirrhosis. , 1989, Gut.

[10]  Vicente Arroyo,et al.  Peripheral arterial vasodilation hypothesis: A proposal for the initiation of renal sodium and water retention in cirrhosis , 1988, Hepatology.

[11]  M. Navasa,et al.  Effects of somatostatin in patients with portal hypertension. , 1988, Hormone research.

[12]  G. Karvountzis,et al.  Enhancement of renal function by a long-acting somatostatin analogue in patients with decompensated cirrhosis. , 1988, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[13]  R. DeFronzo,et al.  Regulation of renal hemodynamics by plasma amino acid and hormone concentrations. , 1987, Kidney international. Supplement.

[14]  T. M. Hayes,et al.  Renal response to intravenous somatostatin in insulin-dependent diabetic patients and normal subjects. , 1987, The Journal of clinical endocrinology and metabolism.

[15]  L. Travis,et al.  Somatostatin limits rise in glomerular filtration rate after a protein meal. , 1987, The Journal of pediatrics.

[16]  V. Arroyo,et al.  Renal function abnormalities, prostaglandins, and effects of nonsteroidal anti-inflammatory drugs in cirrhosis with ascites. An overview with emphasis on pathogenesis. , 1986, The American journal of medicine.

[17]  V. Arroyo,et al.  Urinary excretion of 6-keto-prostaglandin F1 alpha, thromboxane B2 and prostaglandin E2 in cirrhosis with ascites. Relationship to functional renal failure (hepatorenal syndrome). , 1986, Journal of hepatology.

[18]  B. Schneeweiss,et al.  Enhancement of renal function with ornipressin in a patient with decompensated cirrhosis. , 1985, Gut.

[19]  B. Groves,et al.  Interrelationship between cardiac output and vascular resistance as determinants of effective arterial blood volume in cirrhotic patients. , 1985, Kidney international.

[20]  V. Arroyo,et al.  Evidence that renal prostaglandins are involved in renal water metabolism in cirrhosis. , 1984, Kidney international.

[21]  V. Arroyo,et al.  Sympathetic nervous activity, renin‐angiotensin system and renal excretion of prostaglandin E2 in cirrhosis. Relationship to functional renal failure and sodium and water excretion , 1983, European journal of clinical investigation.

[22]  G. A. Nelstrop,et al.  SOMATOSTATIN AND WATER EXCRETION , 1983, The Lancet.

[23]  R. Baldessarini,et al.  False neurotransmitters and hepatic failure. , 1971, Lancet.

[24]  C. Pace,et al.  Somatostatin: Mechanism of Action in Pancreatic Islet β-Cells , 1981, Diabetes.

[25]  J. Bosch,et al.  Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: Comparison with vasopressin , 1981 .

[26]  M. Kirschenbaum,et al.  Effects of alterations in urine flow rate on prostaglandin E excretion in conscious dogs. , 1980, The American journal of physiology.

[27]  K. Polonsky,et al.  Reduction in Portal Vein Blood Flow by Somatostatin , 1979, Diabetes.

[28]  T. Reynolds,et al.  Effect of indomethacin and prostaglandin A, on renal function and plasma renin activity in alcoholic liver disease , 1979 .

[29]  G. Sonnenberg,et al.  [Dosage dependence of the effect of somatostatin on human splanchnic blood flow]. , 1979, Swiss medical weekly.

[30]  S. Efendić,et al.  Circulatory effects of somatostatin in anaesthetized dogs. , 1979, Acta chirurgica Scandinavica.

[31]  J. Peuler,et al.  Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamine. , 1977, Life sciences.

[32]  M. Lie,et al.  Effect of glycine and glucagon on glomerular filtration and renal metabolic rates. , 1977, The American journal of physiology.

[33]  P. Felig,et al.  INFLUENCE OF SOMATOSTATIN ON CARBOHYDRATE DISPOSAL AND ABSORPTION IN DIABETES MELLITUS , 1976, The Lancet.

[34]  P. Bacon,et al.  D-PENICILLAMINE-INDUCED NEPHROPATHY , 1975, The Lancet.

[35]  J. Blonstein.  Letter: Traumatic encephalopathy in a young boxer. , 1974, Lancet.

[36]  I. Valverde,et al.  Elevated plasma glucagon levels in cirrhosis of the liver. , 1973, The New England journal of medicine.

[37]  J. Laragh,et al.  ANGIOTENSIN II, NOREPINEPHRINE, AND RENAL TRANSPORT OF ELECTROLYTES AND WATER IN NORMAL MAN AND IN CIRRHOSIS WITH ASCITES. , 1963, The Journal of clinical investigation.

[38]  S. Papper,et al.  Simultaneous determination of cardiac output and renal function in patients with Laennec's cirrhosis during the administration of the pressor amine, metaraminol. , 1963, The Journal of laboratory and clinical medicine.

[39]  S. Papper,et al.  Acute changes in renal excretion of water and solute in patients with Laennec's cirrhosis, induced by the administration of the pressor amine, metaraminol. , 1961, The Journal of clinical investigation.

[40]  A. Heyrovský,et al.  A new method for the determination of inulin in plasma and urine. , 1956, Clinica chimica acta; international journal of clinical chemistry.